Skip to main content
Year archive

Vivoryon Therapeutics N.V. — 2014 filings

All 10 regulatory filings released by Vivoryon Therapeutics N.V. (VVY) in 2014, sourced directly from the official regulator.

10 Filings
2014 Period
2014 filings (10)
Filing Released Lang
Probiodrug AG: Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2014-11-28 English
Declaration of Voting Results & Voting Rights Announcements 2014
Declaration of Voting Results & Voting Rights Announcements
2014-11-28 English
Probiodrug to present data on therapeutic concept of targeting pyro-Glu Abeta and its frontrunner QC-inhibitor PQ912 at International Alzheimer Conferences
Regulatory Filings
2014-11-17 English
Probiodrug: Capital increase from authorized capital in connection with the Greenshoe option has been completed
Share Issue/Capital Change
2014-11-14 English
Probiodrug :Probiodrug announces the exercise of the Greenshoe Option, increasing the gross proceeds of the Offer to EUR 23.2 million
Share Issue/Capital Change
2014-11-13 English
Declaration of Voting Results & Voting Rights Announcements 2014
Declaration of Voting Results & Voting Rights Announcements
2014-11-12 English
Declaration of Voting Results & Voting Rights Announcements 2014
Declaration of Voting Results & Voting Rights Announcements
2014-11-11 English
Probiodrug AG: Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2014-11-07 English
Dr Inge Lues joins Probiodrug Management Board as Chief Development Officer
Board/Management Information
2014-10-31 English
Increase in share capital Probiodrug AG
Share Issue/Capital Change
2014-10-30 English